Last reviewed · How we verify
NCT03682523
The Breaking "Bad Rest" Study: Interrupting Sedentary Time to Reverse Frailty Levels in Acute Care
NA trial testing Sedentary behavior reduction intervention in Sedentary Lifestyle in 50 participants. Completed in 20 July 2023.
20 July 2023
Quick facts
| Lead sponsor | Olga Theou |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 50 |
| Start date | 7 April 2022 |
| Primary completion | 20 July 2023 |
| Estimated completion | 20 July 2023 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Sedentary behavior reduction intervention
Conditions studied
- Sedentary Lifestyle — all drugs for Sedentary Lifestyle →
Sponsor
Olga Theou
Who can join
Eligibility, any sex, with Sedentary Lifestyle. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will determine whether an intervention aimed at reducing sedentary time in patients admitted to acute care will result in decreased frailty levels at hospital discharge, compared to the current standard of care. All patients will be fitted with accelerometers then randomised to the control or intervention group. The control group will receive only standard of care while in hospital. Participants in the intervention group will engage in daily goal setting for time out-of-bed and have access to real-time feedback on a bedside monitor. Participants in the intervention group will also received assisted mobilization if they have not met their daily goal by the late afternoon. The main outcome is frailty, assessed by a frailty index.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Interrupting bedtime to reverse frailty levels in acute care: a study protocol for the Breaking Bad Rest randomized controlled trial.
Theou O, O'Brien MW, Godin J, Blanchard C, et al · · 2023 · PMID 37563553 · DOI 10.1186/s12877-023-04172-x
Verify or expand the search:
- PubMed search for NCT03682523
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sedentary Lifestyle
Currently open trials in the same condition.
- NCT03511352 — Sedentary Behavior Interrupted: A Trial of Acute Effects on Biomarkers of Healthy Aging · NA · active not recruiting
- NCT03356262 — The QUebec Adipose and Lifestyle InvesTigation in Youth (QUALITY) Cohort · active not recruiting
Other Olga Theou trials
Trials by the same sponsor.
- NCT05970588 — Standing Desk Converter & Habitual Posture · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03682523 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Olga Theou
- Last refreshed: 30 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03682523.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing